AstraZeneca Introduces At-Home FluMist Nasal Spray for Convenient Flu Vaccination

1 min read
Source: CNN
AstraZeneca Introduces At-Home FluMist Nasal Spray for Convenient Flu Vaccination
Photo: CNN
TL;DR Summary

AstraZeneca's FluMist, a nasal spray flu vaccine, is now available for self-administration at home in 34 US states, aiming to improve vaccination rates by offering a convenient, needle-free option for adults and children, with FDA approval and insurance coverage.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

4 min

vs 5 min read

Condensed

95%

83739 words

Want the full story? Read the original article

Read on CNN